HUP0204572A2 - Substituierte bisindolylmaleinimide derivatives, process for their preparation and use and pharmaceutcial compositions containing them - Google Patents
Substituierte bisindolylmaleinimide derivatives, process for their preparation and use and pharmaceutcial compositions containing themInfo
- Publication number
- HUP0204572A2 HUP0204572A2 HU0204572A HUP0204572A HUP0204572A2 HU P0204572 A2 HUP0204572 A2 HU P0204572A2 HU 0204572 A HU0204572 A HU 0204572A HU P0204572 A HUP0204572 A HU P0204572A HU P0204572 A2 HUP0204572 A2 HU P0204572A2
- Authority
- HU
- Hungary
- Prior art keywords
- bisindolylmaleinimide
- substituierte
- derivatives
- preparation
- cancer
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052799 carbon Inorganic materials 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 206010009944 Colon cancer Diseases 0.000 abstract 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000035269 cancer or benign tumor Diseases 0.000 abstract 1
- 208000029742 colonic neoplasm Diseases 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 201000005202 lung cancer Diseases 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
Az (I) általános képletű vegyületek (mely képletben R1 és R1'jelentéseegymástól függetlenül hidrogénatom, kis szénatomszámú alkil-, kisszénatomszámú alkenil- vagy kis szénatomszámú alkinilcsoport; R2jelentése hidrogénatom, nitro-, cianocsoport, halogénatom, kisszénatomszámú alkil-, kis szénatomszámú alkenil-, kis szénatomszámúalkinil- vagy kis szénatomszámú alkoxicsoport; és R' jelentéseheteroarilcsoport, heterociklikus-csoport, heteroaril-csoporttalhelyettesített etilcsoport vagy heteroaril- vagy heterociklikus-csoporttal helyettesített etoxicsoport) és gyógyászatilag alkalmassóik sejtburjánzásos rendellenességek - különösen rák, pl. emlőrák,vastagbélrák vagy tüdőrák - kezelésére alkalmazhatók. A találmánykiterjed a vegyületek előállítására és ezeket taralmazógyógyszerkészítményekre. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17155799P | 1999-12-22 | 1999-12-22 | |
PCT/EP2000/013026 WO2001046178A2 (en) | 1999-12-22 | 2000-12-21 | Substituierte bisindolymaleimide |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0204572A2 true HUP0204572A2 (en) | 2003-05-28 |
HUP0204572A3 HUP0204572A3 (en) | 2004-07-28 |
Family
ID=22624198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0204572A HUP0204572A3 (en) | 1999-12-22 | 2000-12-21 | Substituierte bisindolylmaleinimide derivatives, process for their preparation and use and pharmaceutcial compositions containing them |
Country Status (28)
Country | Link |
---|---|
US (1) | US6281356B1 (hu) |
EP (1) | EP1242409A2 (hu) |
JP (1) | JP2003518112A (hu) |
KR (1) | KR100508741B1 (hu) |
CN (1) | CN1193027C (hu) |
AR (1) | AR027035A1 (hu) |
AU (1) | AU782920B2 (hu) |
BR (1) | BR0016516A (hu) |
CA (1) | CA2394852A1 (hu) |
CO (1) | CO5090902A1 (hu) |
CZ (1) | CZ20022492A3 (hu) |
HK (1) | HK1054382A1 (hu) |
HR (1) | HRP20020536A2 (hu) |
HU (1) | HUP0204572A3 (hu) |
IL (1) | IL150200A0 (hu) |
JO (1) | JO2199B1 (hu) |
MA (1) | MA26860A1 (hu) |
MX (1) | MXPA02006162A (hu) |
MY (1) | MY133682A (hu) |
NO (1) | NO20022927L (hu) |
NZ (1) | NZ519359A (hu) |
PE (1) | PE20011098A1 (hu) |
PL (1) | PL357603A1 (hu) |
RU (1) | RU2261862C2 (hu) |
UY (1) | UY26498A1 (hu) |
WO (1) | WO2001046178A2 (hu) |
YU (1) | YU46302A (hu) |
ZA (1) | ZA200204313B (hu) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030139373A1 (en) * | 2001-11-20 | 2003-07-24 | Breimer Lars Holger | Method for cancer therapy |
AR039209A1 (es) | 2002-04-03 | 2005-02-09 | Novartis Ag | Derivados de indolilmaleimida |
GB0303319D0 (en) | 2003-02-13 | 2003-03-19 | Novartis Ag | Organic compounds |
US20140303121A1 (en) | 2013-03-15 | 2014-10-09 | Plexxikon Inc. | Heterocyclic compounds and uses thereof |
KR102244719B1 (ko) | 2013-03-15 | 2021-04-26 | 플렉시콘 인코퍼레이티드 | 헤테로시클릭 화합물 및 그의 용도 |
HUE045355T2 (hu) | 2016-07-21 | 2019-12-30 | Inst Farmakologii Polskiej Akademii Nauk | Az 5-HT7 szerotoninreceptort kötõ imidazolil-szubsztituált indolszármazékok és gyógyszerészeti készítményeik |
WO2019075243A1 (en) | 2017-10-13 | 2019-04-18 | Plexxikon Inc. | SOLID FORMS OF A COMPOUND FOR MODULATING KINASES |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ280738B6 (cs) | 1988-02-10 | 1996-04-17 | F. Hoffmann - La Roche And Co., Aktiengesellschaft | Substituované pyrroly, jejich použití pro výrobu léčiv a léčiva na jejich bázi |
US5380746A (en) | 1989-05-05 | 1995-01-10 | Goedecke Aktiengesellschaft | Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
CA2015996C (en) * | 1989-05-05 | 2001-08-28 | Hartmut Osswald | Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals |
ATE175873T1 (de) * | 1992-03-20 | 1999-02-15 | Wellcome Found | Weitere indolderivate mit antiviraler wirkung |
AU3761393A (en) | 1992-03-20 | 1993-10-21 | Wellcome Foundation Limited, The | Indole derivatives with antiviral activity |
DE4217964A1 (de) * | 1992-05-30 | 1993-12-02 | Goedecke Ag | Indolocarbazol-Imide und deren Verwendung |
PE91698A1 (es) | 1996-07-29 | 1998-12-24 | Hoffmann La Roche | Pirroles sustituidos |
PE91598A1 (es) | 1996-07-29 | 1998-12-24 | Hoffmann La Roche | Pirroles sustituidos |
PE91498A1 (es) | 1996-07-29 | 1998-12-22 | Hoffmann La Roche | Pirroles sustituidos |
CZ299068B6 (cs) * | 1998-03-17 | 2008-04-16 | F. Hoffmann-La Roche Ag | Substituovaný bisindolylmaleinimid a farmaceutický prostredek s jeho obsahem |
-
2000
- 2000-12-15 US US09/737,685 patent/US6281356B1/en not_active Expired - Fee Related
- 2000-12-19 JO JO2000203A patent/JO2199B1/en active
- 2000-12-20 MY MYPI20006018A patent/MY133682A/en unknown
- 2000-12-20 AR ARP000106792A patent/AR027035A1/es not_active Application Discontinuation
- 2000-12-20 CO CO00096628A patent/CO5090902A1/es unknown
- 2000-12-21 HU HU0204572A patent/HUP0204572A3/hu unknown
- 2000-12-21 EP EP00991984A patent/EP1242409A2/en not_active Withdrawn
- 2000-12-21 BR BR0016516-6A patent/BR0016516A/pt not_active IP Right Cessation
- 2000-12-21 CA CA002394852A patent/CA2394852A1/en not_active Abandoned
- 2000-12-21 KR KR10-2002-7008019A patent/KR100508741B1/ko not_active IP Right Cessation
- 2000-12-21 WO PCT/EP2000/013026 patent/WO2001046178A2/en not_active Application Discontinuation
- 2000-12-21 PL PL00357603A patent/PL357603A1/xx not_active Application Discontinuation
- 2000-12-21 YU YU46302A patent/YU46302A/sh unknown
- 2000-12-21 NZ NZ519359A patent/NZ519359A/en unknown
- 2000-12-21 PE PE2000001386A patent/PE20011098A1/es not_active Application Discontinuation
- 2000-12-21 UY UY26498A patent/UY26498A1/es not_active Application Discontinuation
- 2000-12-21 RU RU2002119557/04A patent/RU2261862C2/ru not_active IP Right Cessation
- 2000-12-21 MX MXPA02006162A patent/MXPA02006162A/es not_active Application Discontinuation
- 2000-12-21 CN CNB008173885A patent/CN1193027C/zh not_active Expired - Fee Related
- 2000-12-21 JP JP2001547088A patent/JP2003518112A/ja active Pending
- 2000-12-21 AU AU37267/01A patent/AU782920B2/en not_active Ceased
- 2000-12-21 CZ CZ20022492A patent/CZ20022492A3/cs unknown
- 2000-12-21 IL IL15020000A patent/IL150200A0/xx unknown
-
2002
- 2002-05-29 ZA ZA200204313A patent/ZA200204313B/en unknown
- 2002-06-18 NO NO20022927A patent/NO20022927L/no not_active Application Discontinuation
- 2002-06-20 HR HR20020536A patent/HRP20020536A2/hr not_active Application Discontinuation
- 2002-06-21 MA MA26707A patent/MA26860A1/fr unknown
-
2003
- 2003-09-15 HK HK03106619A patent/HK1054382A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU782920B2 (en) | 2005-09-08 |
HRP20020536A2 (en) | 2004-08-31 |
KR20020062365A (ko) | 2002-07-25 |
MXPA02006162A (es) | 2002-12-05 |
NO20022927D0 (no) | 2002-06-18 |
PL357603A1 (en) | 2004-07-26 |
MA26860A1 (fr) | 2004-12-20 |
US6281356B1 (en) | 2001-08-28 |
CN1193027C (zh) | 2005-03-16 |
JP2003518112A (ja) | 2003-06-03 |
NO20022927L (no) | 2002-06-18 |
CZ20022492A3 (cs) | 2003-02-12 |
ZA200204313B (en) | 2003-08-29 |
AR027035A1 (es) | 2003-03-12 |
UY26498A1 (es) | 2001-06-29 |
RU2002119557A (ru) | 2004-01-10 |
PE20011098A1 (es) | 2001-10-26 |
JO2199B1 (en) | 2003-12-23 |
HUP0204572A3 (en) | 2004-07-28 |
CO5090902A1 (es) | 2001-10-30 |
YU46302A (sh) | 2005-06-10 |
WO2001046178A3 (en) | 2001-12-06 |
BR0016516A (pt) | 2002-09-17 |
CN1411457A (zh) | 2003-04-16 |
MY133682A (en) | 2007-11-30 |
CA2394852A1 (en) | 2001-06-28 |
AU3726701A (en) | 2001-07-03 |
NZ519359A (en) | 2004-04-30 |
RU2261862C2 (ru) | 2005-10-10 |
WO2001046178A2 (en) | 2001-06-28 |
HK1054382A1 (en) | 2003-11-28 |
IL150200A0 (en) | 2002-12-01 |
EP1242409A2 (en) | 2002-09-25 |
KR100508741B1 (ko) | 2005-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0402352A2 (hu) | Foszfodiészteráz (PDE) 7 inhibitorként alkalmazható pirimidinszármazékok és ezeket tartalmazó gyógyszerkészítmények | |
HUP0203548A2 (hu) | Új spirooxindolszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP0105414A2 (hu) | Pirrolo-izokinolin-, azepino- és diazepino-indol-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
DK0958296T3 (da) | Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme | |
HUP0400704A2 (hu) | Heterociklusos éterrel szubsztituált imidazokinolinok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
ATE437872T1 (de) | Proteinkinaseinhibitoren | |
SE9904505D0 (sv) | Novel compounds | |
SE0202463D0 (sv) | Novel compounds | |
MY132106A (en) | New pyridazin-3(2h)-one derivatives | |
SE0202539D0 (sv) | Compounds | |
HUP0301069A2 (hu) | Új biaril-karboxamidok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
BR0108678A (pt) | Novos compostos | |
ATE316083T1 (de) | Adamantanderivate | |
HRP20041137B1 (hr) | Indolni, azaindolni i srodni heterocikliäśni 4-alkenil piperidinski amidi | |
HUP0400246A2 (hu) | 1,2,4-Trioxolánt tartalmazó maláriaellenes gyógyszerkészítmények és eljárás az előállításukra és az alkalmazásukra | |
MXPA05012247A (es) | Derivados de bencimidazol nuevos. | |
HUP0301685A2 (hu) | Új aporfin-észterek és ezek terápiás alkalmazása, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
ATE277037T1 (de) | Indolderivate zur behandlung von osteoporose | |
HUP0201475A2 (hu) | Heteroarilamidin-, metilamidin- és guanidinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények | |
HUP0204572A2 (en) | Substituierte bisindolylmaleinimide derivatives, process for their preparation and use and pharmaceutcial compositions containing them | |
MXPA05013050A (es) | Derivados de bencimidazol, composiciones que los contienen preparacion de los mismos y usos de los mismos. | |
MA29258B1 (fr) | Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
MXPA02004441A (es) | Derivados de isoxazol como inhibidores de la fosfodiesterasa. | |
HUP0402033A2 (hu) | 2-Amino-4-piridil-metil-tiazolin-származékok alkalmazása az indukálható NO-szintetáz inhibitoraként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
BG106847A (en) | Substituted piperazine derivatives as mtp inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |